• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面突变谱分析和 mRNA 表达分析在不典型慢性髓性白血病与慢性粒单核细胞白血病中的比较。

Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia.

机构信息

Institute of Pathology, Hannover Medical School, Hannover, Germany.

出版信息

Cancer Med. 2019 Feb;8(2):742-750. doi: 10.1002/cam4.1946. Epub 2019 Jan 11.

DOI:10.1002/cam4.1946
PMID:30635983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6382710/
Abstract

Atypical chronic myeloid leukemia (aCML) and chronic myelomonocytic leukemia (CMML) represent two histologically and clinically overlapping myelodysplastic/myeloproliferative neoplasms. Also the mutational landscapes of both entities show congruencies. We analyzed and compared an aCML cohort (n = 26) and a CMML cohort (n = 59) by next-generation sequencing of 25 genes and by an nCounter approach for differential expression in 107 genes. Significant differences were found with regard to the mutation frequency of TET2, SETBP1, and CSF3R. Blast content of the bone marrow revealed an inverse correlation with the mutation status of SETBP1 in aCML and TET2 in CMML, respectively. By linear discriminant analysis, a mutation-based machine learning algorithm was generated which placed 19/26 aCML cases (73%) and 54/59 (92%) CMML cases into the correct category. After multiple correction, differential mRNA expression could be detected between both cohorts in a subset of genes (FLT3, CSF3R, and SETBP1 showed the strongest correlation). However, due to high variances in the mRNA expression, the potential utility for the clinic is limited. We conclude that a medium-sized NGS panel provides a valuable assistance for the correct classification of aCML and CMML.

摘要

非典型慢性髓系白血病(aCML)和慢性髓单核细胞白血病(CMML)代表两种组织学和临床表现重叠的骨髓增生异常/骨髓增殖性肿瘤。这两种实体的突变景观也具有一致性。我们通过下一代测序 25 个基因和 nCounter 方法分析比较了 aCML 队列(n=26)和 CMML 队列(n=59),以检测 107 个基因的差异表达。在 TET2、SETBP1 和 CSF3R 的突变频率方面发现了显著差异。骨髓中原始细胞含量与 aCML 中 SETBP1 的突变状态和 CMML 中 TET2 的突变状态呈负相关。通过线性判别分析,生成了基于突变的机器学习算法,将 19/26(73%)例 aCML 和 54/59(92%)例 CMML 正确分类。经过多次校正后,在一组基因中可以检测到两个队列之间的差异 mRNA 表达(FLT3、CSF3R 和 SETBP1 显示出最强的相关性)。然而,由于 mRNA 表达的高变异性,其在临床上的应用潜力有限。我们得出结论,中等大小的 NGS 面板为正确分类 aCML 和 CMML 提供了有价值的帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0b/6382710/987a8e285507/CAM4-8-742-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0b/6382710/1dfefaa4ba53/CAM4-8-742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0b/6382710/11775e57ca02/CAM4-8-742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0b/6382710/987a8e285507/CAM4-8-742-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0b/6382710/1dfefaa4ba53/CAM4-8-742-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0b/6382710/11775e57ca02/CAM4-8-742-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f0b/6382710/987a8e285507/CAM4-8-742-g003.jpg

相似文献

1
Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia.全面突变谱分析和 mRNA 表达分析在不典型慢性髓性白血病与慢性粒单核细胞白血病中的比较。
Cancer Med. 2019 Feb;8(2):742-750. doi: 10.1002/cam4.1946. Epub 2019 Jan 11.
2
Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.分析非典型慢性髓性白血病和其他髓系恶性肿瘤中的 CSF3R 突变。
Ann Diagn Pathol. 2024 Aug;71:152317. doi: 10.1016/j.anndiagpath.2024.152317. Epub 2024 Apr 18.
3
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.非典型慢性髓系白血病和未另行指定的骨髓增生异常/骨髓增殖性肿瘤:2023年诊断、风险分层及管理更新
Am J Hematol. 2023 Apr;98(4):681-689. doi: 10.1002/ajh.26828. Epub 2023 Jan 4.
4
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.CSF3R、SRSF2和SETBP1突变在慢性嗜中性粒细胞白血病和慢性粒单核细胞白血病中的临床意义
Oncotarget. 2017 Mar 28;8(13):20834-20841. doi: 10.18632/oncotarget.15355.
5
Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.慢性粒单核细胞白血病:骨髓活检免疫组织学的作用
Mod Pathol. 2006 Dec;19(12):1536-45. doi: 10.1038/modpathol.3800707. Epub 2006 Oct 13.
6
The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.外周血、骨髓穿刺液,尤其是骨髓活检切片在鉴别不典型慢性髓细胞白血病与慢性粒细胞白血病及慢性粒单核细胞白血病中的作用。
Eur J Haematol. 2009 Oct;83(4):292-301. doi: 10.1111/j.1600-0609.2009.01283.x. Epub 2009 Jun 2.
7
Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.下一代测序揭示了非典型慢性髓性白血病中 CSF3R 顺式独特突变组合。
J Clin Lab Anal. 2020 Feb;34(2):e23064. doi: 10.1002/jcla.23064. Epub 2019 Nov 6.
8
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.CSF3R 突变型髓系肿瘤:超越慢性中性粒细胞白血病。
Hum Pathol. 2024 Jul;149:66-74. doi: 10.1016/j.humpath.2024.06.008. Epub 2024 Jun 13.
9
Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.骨髓细胞中与髓系造血相关的 microRNA 在非典型慢性髓性白血病和慢性粒单核细胞白血病中的表达。
Ann Hematol. 2011 Mar;90(3):307-13. doi: 10.1007/s00277-010-1072-4. Epub 2010 Sep 15.
10
Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.慢性髓单核细胞白血病和不典型慢性髓性白血病:新的发病机制病变。
Semin Oncol. 2012 Feb;39(1):67-73. doi: 10.1053/j.seminoncol.2011.11.004.

引用本文的文献

1
Expanding the Spectrum of -Mutated Myeloid Neoplasm Beyond Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia: A Comprehensive Analysis of 13 Cases.将-mutated髓系肿瘤的谱系扩展至慢性中性粒细胞白血病和非典型慢性髓系白血病之外:13例病例的综合分析
J Clin Med. 2025 Jul 22;14(15):5174. doi: 10.3390/jcm14155174.
2
Cell-free DNA for detection and monitoring of extramedullary AML relapse.用于检测和监测髓外急性髓系白血病复发的游离DNA
Hemasphere. 2025 Mar 10;9(3):e70097. doi: 10.1002/hem3.70097. eCollection 2025 Mar.
3
Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape.

本文引用的文献

1
Genomic determinants of chronic myelomonocytic leukemia.慢性粒单核细胞白血病的基因组决定因素。
Leukemia. 2017 Dec;31(12):2815-2823. doi: 10.1038/leu.2017.164. Epub 2017 May 30.
2
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.世界卫生组织定义的非典型慢性髓性白血病的靶向二代测序及危险因素鉴定
Am J Hematol. 2017 Jun;92(6):542-548. doi: 10.1002/ajh.24722. Epub 2017 Apr 29.
3
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.
骨髓增殖性肿瘤:当代综述与分子图谱
Int J Mol Sci. 2023 Dec 12;24(24):17383. doi: 10.3390/ijms242417383.
4
Atypical CML: diagnosis and treatment.非典型慢性髓性白血病:诊断与治疗。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):476-482. doi: 10.1182/hematology.2023000448.
5
T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profile.T618I 突变的慢性粒单核细胞白血病:一种具有独特突变谱的增殖亚型。
Leuk Res Rep. 2022 May 6;17:100323. doi: 10.1016/j.lrr.2022.100323. eCollection 2022.
6
Molecular Pathogenesis of -Negative Atypical Chronic Myeloid Leukemia.阴性非典型慢性髓系白血病的分子发病机制
Front Oncol. 2021 Nov 11;11:756348. doi: 10.3389/fonc.2021.756348. eCollection 2021.
7
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.孤立性 17q 等臂染色体的骨髓增生异常/骨髓增殖性肿瘤-不能分类代表一个独特的临床生物学亚组:来自骨髓病理学组的多机构合作研究。
Mod Pathol. 2022 Apr;35(4):470-479. doi: 10.1038/s41379-021-00961-0. Epub 2021 Nov 13.
8
Myelodysplastic syndromes and overlap syndromes.骨髓增生异常综合征及重叠综合征
Blood Res. 2021 Apr 30;56(S1):S51-S64. doi: 10.5045/br.2021.2021010.
9
Genomic Landscape and Risk Stratification in Chronic Myelomonocytic Leukemia.慢性粒单核细胞白血病的基因组景观与风险分层
Curr Hematol Malig Rep. 2021 Jun;16(3):247-255. doi: 10.1007/s11899-021-00613-9. Epub 2021 Mar 3.
10
Genome-wide DNA methylation profiling is able to identify prefibrotic PMF cases at risk for progression to myelofibrosis.全基因组 DNA 甲基化分析能够识别出具有向骨髓纤维化进展风险的前纤维化原发性骨髓纤维化病例。
Clin Epigenetics. 2021 Feb 4;13(1):28. doi: 10.1186/s13148-021-01010-y.
当临床异质性超过遗传异质性时:慢性髓单核细胞白血病的基因组盒外思考。
Blood. 2016 Nov 17;128(20):2381-2387. doi: 10.1182/blood-2016-07-692988. Epub 2016 Oct 5.
4
Evolution of chronic myelomonocytic leukemia to myeloproliferative neoplasm.
Ann Hematol. 2016 Aug;95(8):1377-80. doi: 10.1007/s00277-016-2699-6. Epub 2016 May 25.
5
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
6
Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.使用下一代测序和定制基因检测板进行常规临床突变分析可提高髓系肿瘤的诊断准确性。
Oncotarget. 2016 May 24;7(21):30084-93. doi: 10.18632/oncotarget.8310.
7
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.在对去甲基化药物有反应的慢性粒单核细胞白血病中,突变等位基因负担保持不变。
Nat Commun. 2016 Feb 24;7:10767. doi: 10.1038/ncomms10767.
8
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.慢性粒单核细胞白血病的细胞遗传学和分子异常
Blood Cancer J. 2016 Feb 5;6(2):e393. doi: 10.1038/bcj.2016.5.
9
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia.慢性粒单核细胞白血病中ASXL1与TET2突变之间的预后相互作用
Blood Cancer J. 2016 Jan 15;6(1):e385. doi: 10.1038/bcj.2015.113.
10
Age-related mutations and chronic myelomonocytic leukemia.与年龄相关的突变和慢性粒单核细胞白血病。
Leukemia. 2016 Apr;30(4):906-13. doi: 10.1038/leu.2015.337. Epub 2015 Dec 9.